Skip to content
Eiu Logo Search Menu
  • In-vitro diagnostics
    In-vitro diagnostics
    • Size and Share TrackerThe go-to source for tracking and understanding the global in vitro diagnostics market size, share and trends
    • LabPRO DirectoryTo help your business understand current test, instrument and reagent usage of target customers
    • Company Insights Monitorin-depth reports on China’s top IVD companies’ localised commercial activities in core labs, point-of-care testing, molecular and tissue diagnostics
    • Infectious diseases trend monitorTo help your business strengthen response to shifting disease trends and meet future demand for testing
    • Browse all IVD solutions
  • Surgical devices
  • Medical consumables
  • Custom research
  • Medtech insights
    Medtech insights
    • Clearstate insightsFrom recently published reports offering thought-provoking analysis, to information about new products and services, we will ensure you are always kept informed
    • White papersClearstate’s white papers provide practical business information on a wide range of topics, from macroeconomic events and country affairs to the latest industry trends
    • Essential medtech themesStay up-to-date with trends and forecasts essential for your business
    • Case studiesAn in-depth look at Clearstate’s recent client work, including the challenges our clients faced, our approach to addressing those challenges
  • About
  • Contact
  • EIU Store
  • Search Search
  • Home
  • IVD Gateway
  • Covid-19 testing

Latest Covid-19 testing posts

Filters

Q2 2022 IVD China: point-of-care infectious-disease testing outperforms during the latest covid surge

Q2 2022 IVD China: point-of-care infectious-disease testing outperforms during the latest covid surge

The impact of China’s latest covid-19 surge heads the…

Centralised Diagnostics (CEDx) | Covid-19 testing | In-vitro diagnostics | Infectious Diseases Testing Monitor | Molecular Diagnostics (MDx) | Asia | Centralised Diagnostics (CEDx) | Covid-19 testing | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Tissue Diagnostics (TDx)
Outside of covid-19 diagnostics: Nine out of 16 APAC IVD markets have recovered to pre-pandemic levels

Outside of covid-19 diagnostics: Nine out of 16 APAC IVD markets have recovered to pre-pandemic levels

Asia-Pacific (APAC) IVD markets have grown and exceeded…

Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx) | Asia | Centralised Diagnostics (CEDx) | Covid-19 testing | Infectious Diseases Testing Monitor | IVD Gateway | Molecular Diagnostics (MDx)

Economist Intelligence

  • EIU
  • Corporate Network
  • EIU Store
  • Careers

Help centre

  • Contact us
  • Tutorials

The Economist Group

  • The Economist Group
  • The Economist
  • The Economist Events
  • EIU Perspectives
  • EuroFinance
Follow EIU
Twitter Linkedin Facebook Youtube
  • Cookie policy
  • Terms of access
  • Privacy statement
  • Regulatory affairs
  • Licensing & Permissions
  • Manage cookies
© 2023 The Economist Intelligence Unit Limited. All rights reserved.